![Mihael Polymeropoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mihael Polymeropoulos
Directeur Général chez
VANDA PHARMACEUTICALS INC.
Fortune : 9 M $ au 31/08/2026
Profil
Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc., founded in 2002.
Titles held at Vanda Pharmaceuticals, Inc. include Chairman, President & Chief Executive Officer since 2021.
Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression.
Former jobs include VP & Head-Pharmacogenetics Department at Novartis AG from 1998 to 2003 and Chief-Gene Mapping Section at National Human Genome Research Institute from 1992 to 1998.
Education includes undergraduate studies at the University of Patras.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 1 588 246 ( 2,63% ) | 9 M $ | 31/08/2026 |
Postes actifs de Mihael Polymeropoulos
| Sociétés | Poste | Début |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Directeur Général | 01/05/2003 |
Anciens postes connus de Mihael Polymeropoulos
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2003 |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Corporate Officer/Principal | 01/01/1998 |
Integrated Molecular Analysis of Genome Expression | Fondateur | - |
Formation de Mihael Polymeropoulos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Patras
 University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Integrated Molecular Analysis of Genome Expression | |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
